IL6 and prostate carcinoma: In this study, we demonstrated that transient ectopic AR-V7 overexpression in LNCaP and 22Rv1 prostate cancer cells activate NF-κB with a resultant increase in IL-6 gene expression (Figure 3, Figure 4 and Figure 5).